Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04025840
PHASE4

Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery

Sponsor: Peking University First Hospital

View on ClinicalTrials.gov

Summary

Pancreatic cancer remains a devastating disease with an average 5-year survival rate of about 3-5%. Previous retrospective studies showed that perioperative epidural block and/or dexamethasone are associated with improved outcome after cancer surgery. This randomized trial aims to investigate the effect of perioperative epidural block and/or dexamethasone on long-term survival in patients following pancreatic cancer surgery.

Official title: Effect of Perioperative Epidural Block and Dexamethasone on Outcome of Patients Undergoing Pancreatic Cancer Surgery: a 2×2 Factorial Randomized Controlled Trial

Key Details

Gender

All

Age Range

45 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

260

Start Date

2019-09-11

Completion Date

2026-11

Last Updated

2025-07-31

Healthy Volunteers

No

Interventions

OTHER

Epidural block

Epidural block (with 0.375% ropivacaine) is performed during surgery. Patient-controlled epidural analgesia (with a mixture of 0.12% ropivacaine and 0.5 microgram/ml sufentanyl) is provided after surgery.

DRUG

Dexamethasone

Dexamethasone (10 mg) is administered intravenously before anesthesia induction.

Locations (1)

Peking University First Hospital

Beijing, Beijing Municipality, China